Chronic Pain Treatment: Opioids Reconsidered

Sponsored by BioDelivery Sciences

This activity is not certified for credit.

Date
Tuesday, September 5

Start Time
12:15p

End Time
1:30p

Room
Brera Ballroom
Level 3

Learning Objectives
After completing this activity, participants should be able to:

  • Discuss the need for an appropriate chronic pain treatment against the backdrop of the risk of opioid overdose
  • Review the properties of buprenorphine
  • Explain the benefits of the novel delivery technology of BELBUCA®
  • Review the two pivotal clinical trials that demonstrated the clinical efficacy and safety of BELBUCA® in the treatment of patients with chronic pain
  • Discuss how to properly administer, initiate, and titrate BELBUCA®

Faculty
Joseph Pergolizzi, MD
Richard Rauck, MD

Registration
Pre-registration not required. Please arrive at least 15 minutes prior to start time.

Contact Name
Bridget Beck

Contact Phone
(914) 703-3215

Contact email
bbeck@curryrockefellergroup.com

Share:

Related Content